Edwards is committed to focusing on the patient journey from diagnosis to treatment to lifetime outcome, and Fabunmi has a rare combination of skills and experiences which make her highly qualified for her new role. With compelling data on the high individual and societal costs of valvular disease, Edwards is seeking to address the significant unmet need for care.
Fabunmi will lead Edwards’ evidence development and publication strategy in order to call attention to the prevalence and costs of valvular disease. Importantly, she will also serve as the public face of the company on these issues, engaging key opinion leaders to address the broad lack of awareness.
Fabunmi joins Edwards already possessing subject matter expertise in structural heart disease. Earlier in her career, she served in medical affairs roles for transcatheter aortic valve replacement technologies with Medtronic. Notably, she has also served in medical affairs roles in the pharmaceutical industry, working on heart failure products with Merck and Amylin Pharmaceuticals.
Most recently, Fabunmi served as Senior Director, Medical Affairs with the diabetes company Zafgen. The pharmaceutical industry has blazed the trail on burden of disease data and its use, so Fabunmi’s combination of medical device and pharmaceutical experience in Edwards’ disease space makes her exceptionally qualified for this role. In a career primarily focused on medical affairs, Fabunmi’s experience also encompasses health economics and outcomes research, rendering her almost unique in terms of the skills she brings to Edwards.
About Life Science Partner
Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.